These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16312639)

  • 1. Cefixime: comparative clinical trial on the treatment of lower respiratory tract infection in adults.
    Catena E; Mistretta A; Micillo E; Crimi N; Dericoloso L; Tranchese D; Barbagallo S
    J Chemother; 1989 Jul; 1(4 Suppl):786-8. PubMed ID: 16312639
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefixime: comparative clinical trial on the treatment of upper respiratory tract infection and otitis in adults.
    Puxeddu P; Cadoni BM; Cadeddu L
    J Chemother; 1989 Jul; 1(4 Suppl):780-2. PubMed ID: 16312636
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
    Brückner O; Trautmann M
    J Chemother; 1989 Jul; 1(4 Suppl):782-3. PubMed ID: 16312637
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of respiratory tract infections with augmentin.
    Cioffi R; Turco D; Alfano B; Di Salvatore F; Gnasso P; Mastroianni S
    J Chemother; 1989 Jul; 1(4 Suppl):766-7. PubMed ID: 16312630
    [No Abstract]   [Full Text] [Related]  

  • 5. Cephalexin in lower respiratory infections.
    Practitioner; 1972 Mar; 208(245):421-3. PubMed ID: 4554484
    [No Abstract]   [Full Text] [Related]  

  • 6. [15th Consensus Conference on anti-infectious treatments: management of viral infections of the lower respiratory tract in the immunocompetent adult. Short text].
    ; ; ; ; ; ; ; ;
    Rev Pneumol Clin; 2007 Feb; 63(1):7-18. PubMed ID: 17457279
    [No Abstract]   [Full Text] [Related]  

  • 7. Cefixime once-a-day in the treatment of lower respiratory tract infections in adults.
    Capelli O; Bonucchi ME; Ragno T; Azzolini L; Prandi E; Lega M; Toraldo MD; Velluti G
    J Chemother; 1989 Jul; 1(4 Suppl):775-8. PubMed ID: 16312634
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy of cefadroxil in acute and chronic bacterial infections of the respiratory tract].
    Nosenzo M; Razzetti A; Delle Piane M; Faravelli B; Suffritti G
    Clin Ter; 1983 Mar; 104(5):383-9. PubMed ID: 6342913
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cephalexin in pulmonary infections in children].
    Paschetta G; De Biasi V
    Minerva Pediatr; 1971 Dec; 23(49):2065-71. PubMed ID: 5131194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of a clinical trial of the use of a methoxyamine (cefuroxime) in respiratory tract infections in children].
    Castello D; Sacchetti L; Brero P; Poncini L
    Minerva Pediatr; 1981 Sep; 33(17):881-6. PubMed ID: 7031458
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical contribution to the therapy of acute bronchopneumopathic diseases with the use of antibiotics associated with curative vaccines].
    Fossati C
    Minerva Med; 1968 Jan; 59(5):164-72. PubMed ID: 5639121
    [No Abstract]   [Full Text] [Related]  

  • 12. [How long the antibiotic treatment should be for pulmonary infections?].
    Murris-Espin M
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S83-10S84. PubMed ID: 17127974
    [No Abstract]   [Full Text] [Related]  

  • 13. Cephalexin in lower respiratory tract infections.
    Raff MJ
    Postgrad Med J; 1983; 59 Suppl 5():32-9. PubMed ID: 6364088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of lower respiratory tract infections in immunocompetent adults (community-acquired pneumonia and acute exacerbation of chronic obstructive pulmonary disease): the challenge of a new consensus conference].
    Chidiac C
    Med Mal Infect; 2006 Jan; 36(1):1-3. PubMed ID: 16413722
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The French experience with moxalactam in pneumology].
    Leng B; Imbert Y; Coomans D
    Sem Hop; 1983 Jun; 59(26):1977-80. PubMed ID: 6310790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [D1-sobrerol in the treatment of acute and chronic bronchopulmonary phlogoses].
    Balzano E; De Gaetani G
    Minerva Med; 1973 May; 64(37):1995-2002. PubMed ID: 4578344
    [No Abstract]   [Full Text] [Related]  

  • 18. [Systemic antibiotherapy for the treatment of lower respiratory tract infections. Community acquired pneumonia, acute exacerbation of obstructive chronic bronchitis].
    Chidiac C; ;
    Med Mal Infect; 2011 May; 41(5):221-8. PubMed ID: 21106313
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of lower respiratory tract infections in immunocompetent adults (community-acquired pneumonia and acute exacerbation of chronic obstructive pulmonary disease): The challenge of a new consensus conference].
    Chidiac C
    Med Mal Infect; 2006; 36(11-12):535-7. PubMed ID: 17137740
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the therapy of infectious bronchopneumopathies in children].
    Della Casa R; Vitolo G; Sicuranza R
    Minerva Pediatr; 1967 Mar; 19(10):457-62. PubMed ID: 5607051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.